FDA Tightens CLIA Reagent Import Exemption Path: learn how the new USP <1208> Extractables report requirement may raise compliance costs, affect filings, and reshape delivery planning before Sept. 1, 2026.

Single-use systems validation across facilities can hide major risk gaps. Learn how to compare exposure, supplier controls, and site conditions to make faster, defensible decisions.

FDA draft guidance may speed CLIA reagents import clearance for eligible IVD products. See who qualifies, what validation changes, and how to prepare for faster market entry.

FDA Eases Import Filing for Certain CLIA Reagents: learn how the new FDA guidance may simplify import documents, support lab procurement, and improve supply planning for eligible CLIA reagents.

Cell culture media comparison made practical: compare viability, osmolality, lot consistency, and productivity to choose media that supports stable cell growth and scalable results.